Citigroup Inc Dr Reddys Laboratories LTD Transaction History

Citigroup Inc

$163 Billion
Q4 2024

A detailed history of Citigroup Inc transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Citigroup Inc holds 254,104 shares of RDY stock, worth $3.39 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

254,104

Previous 44,857 466.48%

Holding current value

$3.39 Million

Previous $3.56 Million 12.6%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$13.99 - $79.75 $2.93 Million - $16.7 Million	209,247 Added 466.48%	254,104 $4.01 Million
Q3 2024 Nov 12, 2024	SELL	$75.41 - $84.21 $574,020 - $641,006	-7,612 Reduced 14.51%	44,857 $3.56 Million
Q2 2024 Aug 12, 2024	BUY	$68.26 - $76.19 $546,694 - $610,205	8,009 Added 18.01%	52,469 $4 Million
Q1 2024 May 10, 2024	BUY	$67.36 - $77.59 $133,911 - $154,248	1,988 Added 4.68%	44,460 $3.26 Million
Q4 2023 Feb 09, 2024	SELL	$64.27 - $69.9 $974,654 - $1.06 Million	-15,165 Reduced 26.31%	42,472 $2.96 Million
Q3 2023 Nov 09, 2023	BUY	$61.9 - $72.77 $363,229 - $427,014	5,868 Added 11.33%	57,637 $3.85 Million
Q2 2023 Aug 10, 2023	BUY	$53.34 - $63.11 $912,860 - $1.08 Million	17,114 Added 49.38%	51,769 $3.27 Million
Q1 2023 May 11, 2023	BUY	$51.63 - $56.93 $50,649 - $55,848	981 Added 2.91%	34,655 $1.97 Million
Q4 2022 Feb 09, 2023	SELL	$51.15 - $57.45 $46,904 - $52,681	-917 Reduced 2.65%	33,674 $1.74 Million
Q3 2022 Nov 10, 2022	BUY	$49.9 - $57.32 $582,133 - $668,695	11,666 Added 50.89%	34,591 $1.81 Million
Q2 2022 Aug 10, 2022	BUY	$49.62 - $58.13 $497,837 - $583,218	10,033 Added 77.82%	22,925 $1.27 Million
Q1 2022 May 12, 2022	BUY	$48.27 - $65.25 $142,782 - $193,009	2,958 Added 29.78%	12,892 $718,000
Q4 2021 Feb 10, 2022	SELL	$59.5 - $67.25 $882,623 - $997,586	-14,834 Reduced 59.89%	9,934 $650,000
Q3 2021 Nov 10, 2021	BUY	$60.19 - $75.29 $1.49 Million - $1.86 Million	24,768 New	24,768 $1.61 Million

Others Institutions Holding RDY

# of Institutions

264

Shares Held

107M

Call Options Held

71K

Put Options Held

22.5K

View Full List

About DR REDDYS LABORATORIES LTD

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.22B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

More about RDY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account